Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,088 | 10 | 48.2% |
| Food and Beverage | $2,123 | 37 | 33.1% |
| Education | $1,200 | 1 | 18.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $2,781 | 11 | $0 (2022) |
| Paragon 28, Inc. | $1,209 | 5 | $0 (2023) |
| Steelhead Surgical Inc | $1,200 | 1 | $0 (2021) |
| Next Science LLC | $272.07 | 4 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $270.30 | 4 | $0 (2022) |
| Nevro Corp. | $178.71 | 6 | $0 (2023) |
| Smith+Nephew, Inc. | $128.59 | 6 | $0 (2022) |
| Cardiovascular Systems Inc. | $123.67 | 1 | $0 (2022) |
| Averitas Pharma Inc. | $74.10 | 3 | $0 (2024) |
| GRT US Holding, Inc. | $55.55 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.68 | 1 | Averitas Pharma Inc. ($13.68) |
| 2023 | $1,642 | 16 | Paragon 28, Inc. ($1,209) |
| 2022 | $803.81 | 16 | Stryker Corporation ($213.51) |
| 2021 | $2,157 | 10 | Steelhead Surgical Inc ($1,200) |
| 2019 | $1,795 | 5 | Stryker Corporation ($1,795) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/30/2023 | Paragon 28, Inc. | Portfolio (Device) | Food and Beverage | Cash or cash equivalent | $355.07 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 09/30/2023 | Paragon 28, Inc. | Portfolio (Device) | Travel and Lodging | Cash or cash equivalent | $298.64 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 09/30/2023 | Paragon 28, Inc. | Portfolio (Device) | Travel and Lodging | Cash or cash equivalent | $43.39 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 09/19/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/19/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/07/2023 | Paragon 28, Inc. | Portfolio (Device) | Travel and Lodging | Cash or cash equivalent | $445.05 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 06/29/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $87.00 | General |
| Category: Surgical Site Infection | ||||||
| 05/31/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $144.73 | General |
| Category: Surgical Site Infection | ||||||
| 05/17/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/09/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/29/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $20.17 | General |
| Category: Surgical Site Infection | ||||||
| 03/14/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $20.17 | General |
| Category: Surgical Site Infection | ||||||
| 02/22/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/16/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/23/2023 | Paragon 28, Inc. | Silverback (Device) | Food and Beverage | Cash or cash equivalent | $66.88 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 01/18/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/29/2022 | Zimmer Biomet Holdings, Inc. | Allograft (Device) | Food and Beverage | In-kind items and services | $97.47 | General |
| Category: Sports Medicine | ||||||
| 12/13/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/01/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Pain Management | ||||||
| 11/01/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Pain Management | ||||||
| 09/20/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Pain Management | ||||||
| 09/01/2022 | DePuy Synthes Sales Inc. | MOTOBAND (Device) | Food and Beverage | In-kind items and services | $47.40 | General |
| Category: Trauma | ||||||
| 08/18/2022 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Extra Cellular Matrix | ||||||
| 07/06/2022 | Smith+Nephew, Inc. | STRAVIX (Medical Supply) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Extremities & Limb Restoration | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 259 | 456 | $98,988 | $33,306 |
| 2022 | 8 | 284 | 416 | $93,308 | $29,944 |
| 2021 | 3 | 43 | 45 | $10,745 | $3,737 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 135 | $25,083 | $9,317 | 37.1% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 18 | 85 | $25,058 | $8,724 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $17,186 | $4,774 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 49 | $13,250 | $4,586 | 34.6% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 35 | 66 | $7,492 | $2,120 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $5,636 | $1,637 | 29.0% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 16 | 22 | $2,652 | $1,171 | 44.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 32 | 36 | $2,629 | $978.98 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $29,462 | $8,355 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 115 | $22,087 | $8,139 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 37 | $10,040 | $3,592 | 35.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 13 | 37 | $10,908 | $3,584 | 32.9% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 33 | 59 | $6,698 | $1,979 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $8,320 | $1,910 | 23.0% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 17 | 22 | $2,652 | $1,267 | 47.8% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 29 | 43 | $3,141 | $1,117 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $7,366 | $2,400 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,357 | $928.62 | 39.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 13 | 14 | $1,023 | $408.52 | 40.0% |
About Dr. Sean Lee, DPM
Dr. Sean Lee, DPM is a Primary Podiatric Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2019. The National Provider Identifier (NPI) number assigned to this provider is 1134692486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Lee, DPM has received a total of $6,412 in payments from pharmaceutical and medical device companies, with $13.68 received in 2024. These payments were reported across 48 transactions from 13 companies. The most common payment nature is "Travel and Lodging" ($3,088).
As a Medicare-enrolled provider, Lee has provided services to 586 Medicare beneficiaries, totaling 917 services with total Medicare billing of $66,987. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Primary Podiatric Medicine
- Other Specialties Foot & Ankle Surgery
- Location Los Angeles, CA
- Active Since 01/09/2019
- Last Updated 08/14/2025
- Taxonomy Code 213EP1101X
- Entity Type Individual
- NPI Number 1134692486
Products in Payments
- ANCHORAGE (Device) $1,866
- Portfolio (Device) $1,142
- PROPHECY (Device) $435.41
- SurgX (Device) $272.07
- HOFFMANN (Device) $175.00
- INFINITY (Device) $149.87
- VARIAX (Device) $142.96
- Diamondback Peripheral (Device) $123.67
- Stratum Foot Plating System (Device) $111.87
- Omnia (Device) $103.89
- Allograft (Device) $97.47
- GRAFIX PL (Medical Supply) $94.56
- Senza (Device) $74.82
- QUTENZA (Drug) $74.10
- Silverback (Device) $66.88
- Nextremity InCore (Device) $60.96
- Qutenza (Drug) $55.55
- MOTOBAND (Device) $47.40
- INTELLIS ADAPTIVESTIM (Device) $25.73
- VENASEAL (Device) $23.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.